台灣血栓暨止血學會

時間

題目

講者

09:20-09:25

開幕致詞

彭慶添理事長

專題演講一 Moderator

09:25-10:05

(視訊)Treatment of hemophilia in the future - from standard to novel therapies

Dr. Malec Lynn M. Malec

沈銘鏡教授

10:05-10:15

Q & A

10:15-10:35

Coffee Break

會員演講一 Moderator : 邱世欣教授

10:35-10:50

Hemoperitoneum During Ovulation in Two Cases of Type 2 von Willebrand Disease

宋家瑜 醫師/彰基

10:50-11:05

Analysis of novel factor IX for treating hemophilia in a genetically-modified hemophilia B mouse model

陳立夫 / 台大醫技系

11:05-11:25

Clinical diagnosis and treatment of von Willebrand disease

陳宇欽醫師/三總

Lunch Symposiums 11:40-13:40(非台灣血栓暨止血學會之會員，午餐請自理)

11:25-12:05

(視訊)Forefront of Hemophilia A treatment: Toward “Beyond ABR” (中外)

Prof. Midori Shima 

沈銘鏡 教授

12:05-12:45

State of the art in therapeutic strategies of immune thrombocytopenia in Taiwan(Novartis)

張 鴻 醫師/

林口長庚

邱世欣 教授

專題演講二 Moderator

12:45-13:25

Hemophilia gene thearpy-AAV based viral vectors and clotting factor gene variants

林淑華 教授/

台大醫學院

林東燦 教授

13:25-13:30

Q & A

13:30-14:00

會員大會

14:00-14:20

Coffee Break

COVID-19 專題研討 Moderator : 沈銘鏡 教授

14:20-14:45

Thrombotic thrombocytopenia and other hemostatic abnormality in severe COVID-19 infection 

王建得醫師/中榮

14:45-15:10

COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT)

周聖傑醫師/台大

15:10-15:35

Anti PF-4 antibody tests and other laboratory diagnosis in VITT

林正修醫師/彰基

15:35-15:40

閉幕致詞

沈銘鏡 榮譽理事長

Satellite Symposiums Moderator

15:40-16:2

Individualized Care of Hemophilia A: The Importance of Factor VIII Supplement Treatment(Bayer)

王建得 醫師/

中榮

沈銘鏡 教授

16:20-17:00

(視訊)Clinical presentation and differential diagnosis of purpura fulminans (Takeda)

Prof. Arwa Alyamani

沈銘鏡 教授